Sale!

GATA6 Gene Atrial Septal Defect Type 9 NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The GATA6 Gene Atrial Septal Defect Type 9 NGS Genetic DNA Test is a specialized genetic analysis that identifies mutations in the GATA6 gene associated with congenital heart defects. This comprehensive test utilizes Next Generation Sequencing technology to detect specific genetic variations that cause atrial septal defects and other cardiac abnormalities. Individuals with family history of congenital heart disease, unexplained cardiac symptoms, or previous diagnosis of atrial septal defects should consider this test. The test provides crucial information for personalized treatment planning, family planning decisions, and early intervention strategies. Results are typically available within 3-4 weeks from blood or DNA samples. The test is priced at $500 USD with a regular price of $700 USD, making advanced genetic cardiac testing accessible to patients nationwide.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

GATA6 Gene Atrial Septal Defect Type 9 NGS Genetic DNA Test

Comprehensive Introduction to Cardiac Genetic Testing

The GATA6 Gene Atrial Septal Defect Type 9 NGS Genetic DNA Test represents a breakthrough in cardiovascular genetic diagnostics. This advanced testing methodology focuses on identifying specific mutations in the GATA6 gene, which plays a critical role in cardiac development and function. Atrial septal defects are among the most common congenital heart conditions, affecting thousands of individuals annually in the United States. Understanding the genetic basis of these conditions enables more targeted interventions and personalized treatment approaches.

Genetic testing for cardiac conditions has revolutionized how healthcare providers approach congenital heart disease management. The GATA6 gene encodes a transcription factor essential for proper heart formation during embryonic development. Mutations in this gene can lead to structural abnormalities in the heart’s chambers, particularly affecting the atrial septum that separates the upper chambers of the heart.

What This Test Measures and Detects

This specialized genetic analysis utilizes Next Generation Sequencing (NGS) technology to comprehensively examine the GATA6 gene for:

  • Point mutations and single nucleotide variations
  • Insertions and deletions affecting gene function
  • Regulatory region abnormalities
  • Copy number variations
  • Pathogenic variants associated with atrial septal defects

The test specifically targets genetic markers linked to Atrial Septal Defect Type 9, providing clinicians with precise information about the underlying genetic cause of cardiac abnormalities. This level of detail enables more accurate diagnosis and facilitates targeted treatment planning.

Who Should Consider This Genetic Test

Clinical Indications and Symptoms

This test is particularly recommended for individuals experiencing:

  • Unexplained cardiac symptoms in infancy or childhood
  • Family history of congenital heart defects
  • Previous diagnosis of atrial septal defects
  • Recurrent respiratory infections or breathing difficulties
  • Poor weight gain and growth in infants
  • Fatigue and exercise intolerance
  • Cyanosis (bluish skin coloration)
  • Heart murmur detected during physical examination

High-Risk Populations

  • Individuals with first-degree relatives diagnosed with congenital heart disease
  • Patients with multiple family members affected by cardiac conditions
  • Couples planning pregnancy with family history of genetic heart disorders
  • Children presenting with developmental cardiac abnormalities

Significant Benefits of Genetic Testing

Undergoing the GATA6 Gene Atrial Septal Defect Type 9 NGS Genetic DNA Test provides numerous advantages:

Medical Management Benefits

  • Early Intervention: Enables proactive management of cardiac conditions before symptoms become severe
  • Personalized Treatment: Guides development of customized treatment plans based on genetic profile
  • Surgical Planning: Provides crucial information for cardiac surgeons when intervention is necessary
  • Medication Optimization: Helps select appropriate medications and avoid potentially harmful treatments

Family Planning Advantages

  • Genetic Counseling: Empowers informed family planning decisions
  • Risk Assessment: Determines recurrence risks for future pregnancies
  • Prenatal Testing: Enables early detection during pregnancy when indicated
  • Extended Family Screening: Identifies at-risk relatives who may benefit from testing

Understanding Your Test Results

Interpretation Guidelines

Test results are categorized to provide clear clinical guidance:

Positive Result

A positive result indicates the presence of a pathogenic mutation in the GATA6 gene associated with atrial septal defects. This finding:

  • Confirms the genetic basis of cardiac symptoms
  • Guides appropriate cardiac monitoring and management
  • Informs family members about potential genetic risks
  • Supports decisions regarding surgical interventions when necessary

Negative Result

A negative result suggests no detectable mutations in the GATA6 gene. This outcome:

  • May indicate other genetic or environmental causes for cardiac symptoms
  • Does not completely rule out genetic contributions from other genes
  • Should be interpreted in context of clinical symptoms and family history
  • May warrant additional genetic testing for other cardiac genes

Variant of Uncertain Significance

Some results may identify genetic changes with unclear clinical implications. In such cases:

  • Additional family studies may be recommended
  • Ongoing research may provide future clarity
  • Clinical correlation with symptoms remains essential
  • Periodic re-evaluation may be necessary as knowledge advances

Test Pricing and Availability

Test Component Price (USD)
Discount Price $500
Regular Price $700
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States with convenient locations in major metropolitan areas including:

  • New York City and surrounding regions
  • Los Angeles and Southern California
  • Chicago and Illinois metropolitan area
  • Houston and Texas Gulf Coast
  • Phoenix and Arizona communities
  • Philadelphia and Pennsylvania region
  • San Antonio and South Texas
  • San Diego and California border areas
  • Dallas and North Texas
  • San Jose and Silicon Valley

Pre-Test Preparation Requirements

To ensure optimal testing outcomes, please prepare the following:

  • Complete clinical history documentation
  • Genetic counseling session to develop family pedigree chart
  • Information about affected family members
  • Previous cardiac testing results and reports
  • Current medication list and medical conditions

Take Action for Your Cardiac Health

Don’t wait to get the answers you need about your cardiac health. Our team of genetic specialists and cardiologists are ready to provide comprehensive testing and counseling services. Early detection and proper management of genetic cardiac conditions can significantly improve quality of life and long-term outcomes.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and testing appointment. Our compassionate staff will guide you through the entire process, from initial consultation to result interpretation and follow-up care planning.

Take the first step toward understanding your genetic cardiac health. Book your GATA6 Gene Atrial Septal Defect Type 9 NGS Genetic DNA Test today and gain valuable insights for your medical journey.